Propofol Market Analysis

  • Report ID: 3132
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Propofol Segmentation

The propofol market is segmented by application into procedural sedation and general anesthesia, out of which, the general anesthesia segment is estimated to hold a significant market share on the back of rising number of surgical procedures across the globe coupled with the easy availability of the drug. As per the U.S. National Institutes of Health, every day about 60,000 people in the nation undergo surgery under general anesthesia. Apart from this, the ability of anesthesia to enable painless medical procedures that lead to healthier and longer lives is also evaluated to boost growth of this market segment in the future. Additionally, on the basis of distribution channel, the segment for hospitals is expected to garner the largest market share over the forecast period, which can be ascribed to the high number of admissions and abundant availability of appropriate medical equipment in a hospital facility. 

Our in-depth analysis of the global propofol market includes the following segments:

 

By Application

  • Procedural Sedation
  • General Anesthesia

      

By Distribution Channel

  • Ambulatory Surgery Centers
  • Ophthalmic Clinics
  • Hospitals
  • Dental Clinics
  • Specialty Clinics

By End-user

 

  • Seditionist
  • Anesthesiologist
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of propofol is assessed at USD 1.09 billion.

Propofol Market size was over USD 1.04 billion in 2024 and is projected to reach USD 2.01 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037.

North America industry is expected to dominate majority revenue share by 2037, on the back of increase in the number of well-established healthcare facilities, high adoption of minimally invasive surgical procedures and easy availability of drugs in the region.

The major players in the market are Pfizer Inc., Bachem Holding AG, Porton Fine Chemicals Ltd., SI Group, Inc., AstraZeneca plc, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos